Bourdon David's Form 4 filing
LifeStance Health Group, Inc. (LFST) · filed Mar 12, 2024
- Accession no.
- 0000950170-24-030447
- Filed
- Mar 12, 2024
- Trade date
- Mar 8-11, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $407.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bourdon DavidCIK 0001823690 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Stock | AGrant or awardAcquired | +104,022 | $0.00 | $0 | 368,038 | Direct | |
| Mar 8, 2024 | Common Stock | AGrant or awardAcquired | +124,644 | $0.00 | $0 | 492,682 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −58,826 | $6.93 | −$407,664.18 | 433,856 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.